japan endovascular treatment conference 2016 jet2016 general presentation
TRANSCRIPT
![Page 1: Japan Endovascular Treatment Conference 2016 JET2016 General Presentation](https://reader036.vdocuments.net/reader036/viewer/2022082419/5a4d1b8e7f8b9ab0599c020a/html5/thumbnails/1.jpg)
Japan Endovascular Treatment Conference 2016
JET2016 General Presentation
![Page 2: Japan Endovascular Treatment Conference 2016 JET2016 General Presentation](https://reader036.vdocuments.net/reader036/viewer/2022082419/5a4d1b8e7f8b9ab0599c020a/html5/thumbnails/2.jpg)
COI Disclosure; Name, MD.
For the 12 months preceding this CME activity, I disclose the following types of financial relationships:•Honoraria received from:•Consulted for:•Held common stock in:•Research, clinical trial, or drug study funds received
from:• I WILL or WILL NOT be discussing products that are
investigational or not labeled for use under discussion.
![Page 3: Japan Endovascular Treatment Conference 2016 JET2016 General Presentation](https://reader036.vdocuments.net/reader036/viewer/2022082419/5a4d1b8e7f8b9ab0599c020a/html5/thumbnails/3.jpg)
![Page 4: Japan Endovascular Treatment Conference 2016 JET2016 General Presentation](https://reader036.vdocuments.net/reader036/viewer/2022082419/5a4d1b8e7f8b9ab0599c020a/html5/thumbnails/4.jpg)
![Page 5: Japan Endovascular Treatment Conference 2016 JET2016 General Presentation](https://reader036.vdocuments.net/reader036/viewer/2022082419/5a4d1b8e7f8b9ab0599c020a/html5/thumbnails/5.jpg)
Thank you for your attention
JET2016 Fukuoka, Japan
February 19(Fri)-21(Sun)2016